Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
HSHS Medical Group, Effingham, Illinois, USA.
Gastrointest Endosc. 2021 Feb;93(2):334-342.e1. doi: 10.1016/j.gie.2020.09.021. Epub 2020 Nov 18.
A subcommittee of the Association for Bariatric Endoscopy, a division of the American Society for Gastrointestinal Endoscopy (ASGE) comprising experts in the subject area, performed this systematic review and meta-analysis. The systematic review and meta-analysis was reviewed by the ASGE Technology Committee and was ultimately submitted to the ASGE Governing Board for approval. The systematic review and meta-analysis underwent peer review by outside experts in statistics and meta-analysis before receiving final ASGE Governing Board approval. The Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) initiative is an ASGE program whose objectives are to identify important clinical questions related to endoscopy and to establish a priori diagnostic and/or therapeutic thresholds for endoscopic technologies designed to resolve these clinical questions. Once endoscopic technologies meet an established PIVI threshold, those technologies are appropriate to incorporate into clinical practice, presuming the appropriate training in that endoscopic technology has been achieved. ASGE encourages and supports the appropriate use of technologies that meet its established PIVI thresholds.
美国胃肠内镜学会(ASGE)的减肥内镜协会的一个下属委员会,由该领域的专家组成,进行了本次系统评价和荟萃分析。该系统评价和荟萃分析由 ASGE 技术委员会审查,并最终提交给 ASGE 理事会批准。该系统评价和荟萃分析在获得 ASGE 理事会最终批准之前,经过了统计学和荟萃分析方面的外部专家的同行评审。保存和纳入有价值的内镜创新(PIVI)倡议是 ASGE 的一个项目,其目标是确定与内镜相关的重要临床问题,并为旨在解决这些临床问题的内镜技术建立事先诊断和/或治疗阈值。一旦内镜技术达到既定的 PIVI 阈值,这些技术就适合纳入临床实践,前提是已经在该内镜技术方面进行了适当的培训。ASGE 鼓励和支持使用符合其既定 PIVI 阈值的技术。